Latest Market News

Ausgold Limited has raised A$35 million through a well-supported placement to accelerate its Katanning Gold Project in Western Australia towards a final investment decision.

Chariot Corporation Ltd has had its trading suspension lifted following an announcement about a proposed acquisition, signaling renewed market interest.

Chariot Corporation Ltd is set to acquire a 66.7% interest in a substantial Nigerian lithium portfolio, marking a strategic entry into Africa’s burgeoning lithium sector with a US$10 million funding commitment.

Aguia Resources has scrapped its planned convertible note issue, converting $750,000 in subscriptions into a secured loan with a potential share conversion feature, pending shareholder approval.

Mindax Limited has raised $1.6 million through a discounted share placement to fund development and exploration activities at its Mt Forrest Iron Project and gold assets.

G50 Corp has confirmed a significant new precious metals discovery at its Golconda Project in Arizona, revealing extensive gold, silver, and zinc mineralization from its latest drilling program. The results also highlight notable gallium mineralization, underscoring the project's strategic value.

Imricor Medical Systems has secured key European regulatory approvals for its second-generation NorthStar system and initiated its commercial launch, while US FDA submissions progress amid some delays.

Australian Rare Earths Limited (ASX, AR3) has acquired exploration license EL6895, adding 972 km² to its Overland Uranium Project and uncovering significant near-surface uranium potential from historic data. Drilling is set to resume in July 2025 to test this promising new target alongside existing deeper uranium prospects.

Osmond Resources has significantly expanded its Orion EU Critical Minerals Project by 160%, with promising assay results and a planned drilling program to confirm mineral continuity. The company is positioning itself to benefit from strong EU demand for rare earths, titanium, and silicon metals.

Race Oncology has secured key ethics approvals to launch its Phase 1 RC220 trial at two major Hong Kong hospitals, marking a strategic expansion beyond Australia to accelerate patient recruitment and explore cardioprotective benefits.

Kinterra Infrastructure has increased its takeover offer for New World Resources shares to A$0.063, with a potential rise to A$0.064 if it secures over 30% ownership. This move intensifies the takeover battle against rival CAML, promising quicker payments and stronger funding assurances.

Orthocell has achieved a significant milestone by recording its first US sales revenue for Remplir™, its flagship nerve repair product, shortly after FDA clearance and initial surgical use.